WuXi STA and Dizal sign CMC Development and Manufacturing Agreement
WuXi STA will now provide Dizal integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Torrent Pharma posts Q4 net loss of Rs 152 cr
Also, for the fiscal year ended March 2019, the company posted a net profit of Rs 436 crore as against Rs 678 crore for the…
Glenmark gets US FDA nod for Solifenacin Succinate Tablets
The US FDA approved the Abbreviated New Drug Application for Solifenacin Succinate Tablets, which are a generic version of…
GlaxoSmithKline reports an eight per cent revenue growth for FY19
The company recently released its consolidated financial results, wherein it reported a 21 per cent hike in net revenue for FY19
Dr Reddy’s to spend up to USD 300 mn on R&D in FY 2019
The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the…
AstraZeneca moves US court against Aurobindo Pharma on generic
The AstraZeneca alleged that the Indian drug makers proposed generic Daliresp would infringe the patents on three counts and…
TAKE Solution announces consolidated financial results
The company reported a 28.5 per cent growth in revenues at Rs 20,390 mn and a growth of 11.6 per cent in net profits for FY19;…
Jubilant Life Sciences announces consolidated financial results for Q4 & 12M’FY19 Results
The company reported a 21 per cent hike in YoY total revenue at Rs. 9,111 Crore
Dr Reddy’s Q4 PAT up 44 per cent at Rs 434 crore
The revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same…
Changing brand name mandatory when changing drug composition: CDSCO
The drug regulator stated that the practice of changing the key therapeutic ingredients in a drug formulation without changing the…
Shilpa Medicare gets USFDA nod for cancer drug
The company has received US FDA final approval for its ANDA for Docetaxel Injection USP in the strengths of 20 mg/mL, 80 mg/4 mL…
Biocon and Mylan to announce the final overall survival data for Ogivri
Ogivri is the first biosimilar for Herceptin approved by the US Food and Drug Administration (FDA) for all indications including…
Pfizer’s atopic dermatitis treatment meets goals in late-stage study
The drug developed by the firm, Abrocitinib, was found to have significantly improved clearing of the skin in patients as compared…
Scientists in new push to control cancer before curing it
Centre for Cancer Drug Discovery, a new centre being set up will “seek to meet the challenge of cancer evolution head on” by…
Lupin gets 3 observations from USFDA for Aurangabad plant
The USFDA carried out the inspection at the plant from May 6 to May 15
Dr. Reddy’s launches Daptomycin for Injection in US
Daptomycin for Injection is a a therapeutic equivalent generic version of Cubicin for Injection
IDMA organises Marketing and Sales Conference, 2019 in Mumbai
The theme of this year's conference was “Growing Brands to Level Next”
LifeArc and GVK BIO celebrate 10 years of partnership
The longevity of this partnership, and the transformative results of the collaboration, serve as a testament to the capabilities…
Seven Indian pharma companies among the 20 sued by the US
44 US states, 20 drug companies, Teva Pharmaceuticals, Aurobindo Pharma, Lupin Wockhardt, Zydus Pharma, Dr Reddy’s Laboratories,…
CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’
Market looks well set for regional boom as second CPhI Middle East & Africa launches in Dubai: Madhukar Tanna, Chief Executive…